47
https://pubmed.ncbi.nlm.nih.gov/38117543
The abstract discusses the need for updated classification, standardized assessment, and individualized management of generalized myasthenia gravis (gMG) to improve patient care and better utilize new, targeted treatments and biomarkers for this disease.